Article: Nicotinamide Riboside Restores Intestinal Health and Mitochondrial Function in Colitis: Preclinical Findings

PrevNext
Digestive/Gut Health Gastrointestinal Diseases Preclinical

Nicotinamide Riboside Restores Intestinal Health and Mitochondrial Function in Colitis: Preclinical Findings

Synopsis

Reduced levels of PGC1α, a key regulator of cellular energy, contribute to inflammatory bowel disease (IBD). In both mice with experimental colitis and humans with ulcerative colitis, NAD+ levels in the intestinal lining were significantly lowered, while the activity of the NAD-consuming enzyme PARP1 was increased. Treatment with nicotinamide riboside (NR), an NAD+ precursor, restored NAD+ levels, improved mitochondrial function, increased active PGC1α, and reduced disease severity. However, mice lacking PGC1α in the intestinal lining did not benefit, showing that PGC1α is essential for these effects. These findings suggest that boosting NAD+ with NR could be a promising strategy for supporting intestinal health in IBD.

Journal

Frontiers in Immunology

Share

Read more

Case Study

Clinical Outcomes of SAMe and Nicotinamide Riboside Supplementation in a Child with Arts Syndrome: Case Report

Objectives To examine the effects of supplementation of S-adenosylmethionine (SAMe) and NR in a child with Arts syndrome and compare to previous Arts syndrome patients who received SAMe with or wi...

Read more
Amyotrophic Lateral Sclerosis (ALS)

Effect of the Mediterranean Diet Supplemented with Nicotinamide Riboside, Pterostilbene, and/or Coconut Oil in ALS Patients: Pilot Clinical Findings

Objectives To assess the effects of a Mediterranean diet supplemented with nicotinamide riboside (NR) and pterostilbene, with or without coconut oil, on body weight, composition, BMI, and overall ...

Read more